Signal active
Organization
Contact Information
Overview
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening.
Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.
About
Health Care, Medical, Medical Device
2003
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Mitralign headquartered in United States, North America, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $25.2B in funding across 144 round(s). With a team of 51-100 employees, Mitralign is actively contributing to advancements in Health Care. Their latest funding round, Series D - Mitralign, raised $35.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
12
6
0
$175.0M
Details
7
Mitralign has raised a total of $175.0M in funding over 7 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2006 | Early Stage Venture | 3.3M | ||
2004 | Early Stage Venture | 3.5M | ||
2007 | Late Stage Venture | 24.0M | ||
2012 | Late Stage Venture | 35.0M |
Investors
Mitralign is funded by 50 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Saints Capital | - | FUNDING ROUND - Saints Capital | 35.0M |
Medtronic | - | FUNDING ROUND - Medtronic | 35.0M |
Mitralign | - | FUNDING ROUND - Mitralign | 35.0M |
Johnson & Johnson Development Corporation | - | FUNDING ROUND - Johnson & Johnson Development Corporation | 35.0M |
Recent Activity
There is no recent news or activity for this profile.